The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis

BackgroundFocal adhesion kinase (FAK) is a non-receptor tyrosine kinase that plays an important role in survival signaling. FAK has been shown to be overexpressed in breast cancer tumors at early stages of tumorigenesis.MethodsTo study the direct effect of FAK on breast tumorigenesis, we developed Tet-ON (tetracycline-inducible) system of MCF-7 breast cancer cells stably transfected with FAK or dominant-negative, C-terminal domain of FAK (FAK-CD), and also FAKsiRNA with silenced FAK MCF-7 stable cell line. Increased expression of FAK in isogenic Tet-inducible MCF-7 cells caused increased cell growth, adhesion and soft agar colony formation in vitro, while expression of dominant-negative FAK inhibitor caused inhibition of these cellular processes. To study the role of induced FAK and FAK-CD in vivo, we inoculated these Tet-inducible cells in nude mice to generate tumors in the presence or absence of doxycycline in the drinking water. FAKsiRNA-MCF-7 cells were also injected into nude mice to generate xenograft tumors.ResultsInduction of FAK resulted in significant increased tumorigenesis, while induced FAK-CD resulted in decreased tumorigenesis. Taq Man Low Density Array assay demonstrated specific induction of FAKmRNA in MCF-7-Tet-ON-FAK cells. DMP1, encoding cyclin D binding myb-like protein 1 was one of the genes specifically affected by Tet-inducible FAK or FAK-CD in breast xenograft tumors. In addition, silencing of FAK in MCF-7 cells with FAK siRNA caused increased cell rounding, decreased cell viability in vitro and inhibited tumorigenesis in vivo. Importantly, Affymetrix microarray gene profiling analysis using Human Genome U133A GeneChips revealed >4300 genes, known to be involved in apoptosis, cell cycle, and adhesion that were significantly down- or up-regulated (p < 0.05) by FAKsiRNA.ConclusionThus, these data for the first time demonstrate the direct effect of FAK expression and function on MCF-7 breast cancer tumorigenesis in vivo and reveal specific expression of genes affected by silencing of FAK.

[1]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[2]  D. McConkey,et al.  Transcription Factor AP-2α Is Preferentially Cleaved by Caspase 6 and Degraded by Proteasome during Tumor Necrosis Factor Alpha-Induced Apoptosis in Breast Cancer Cells , 2001, Molecular and Cellular Biology.

[3]  G. Hu,et al.  PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma , 2008, FEBS letters.

[4]  T. Bismar,et al.  Tumorigenesis and Neoplastic Progression Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness , 2010 .

[5]  J. Schlessinger,et al.  Crystal structures of free and ligand-bound focal adhesion targeting domain of Pyk2. , 2009, Biochemical and biophysical research communications.

[6]  S. Hanks,et al.  Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  I. Ellis,et al.  Immunohistochemical analysis reveals a tumour suppressor‐like role for the transcription factor AP‐2 in invasive breast cancer , 1999, The Journal of pathology.

[8]  W. Cance,et al.  The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  C. Turner,et al.  Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly , 1992, The Journal of cell biology.

[10]  D. Brenner,et al.  The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.

[11]  J. Parsons,et al.  pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Schlaepfer,et al.  Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model , 2006, Oncogene.

[13]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[14]  G. Plopper,et al.  Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells. , 2006, Biochemical and biophysical research communications.

[15]  E. Parkinson,et al.  Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells , 1999, Oncogene.

[16]  J. M. García-Martínez,et al.  Role of c-Src in Human MCF7 Breast Cancer Cell Tumorigenesis* , 2006, Journal of Biological Chemistry.

[17]  J. Parsons,et al.  Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene , 1989, Molecular and cellular biology.

[18]  John W M Martens,et al.  Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. , 2005, Cancer research.

[19]  J. Parsons,et al.  Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK , 1994, Molecular and cellular biology.

[20]  R L Juliano,et al.  Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Jiayuh Lin,et al.  Stat3 upregulates MEK5 expression in human breast cancer cells , 2004, Oncogene.

[22]  F. Zindy,et al.  Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. , 2001, Genes & development.

[23]  W. Cance,et al.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer , 2006, Annals of Surgical Oncology.

[24]  P. Sismondi,et al.  AP-2 and AP-2 regulate tumor progression via specific genetic programs , 2008 .

[25]  R. Cardiff,et al.  Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression , 2007, Proceedings of the National Academy of Sciences.

[26]  Jae K. Lee,et al.  Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays , 2003, Bioinform..

[27]  V. Golubovskaya,et al.  Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[28]  V. Denis,et al.  Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells , 2008, Molecular Cancer.

[29]  Kazushi Inoue,et al.  Dmp1 and tumor suppression , 2007, Oncogene.

[30]  C. Livasy,et al.  Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis , 2004, Breast Cancer Research and Treatment.

[31]  D. Shalloway,et al.  Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation , 1992, Nature.

[32]  Joseph Geradts,et al.  High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype , 2005, Modern Pathology.

[33]  M. Frame,et al.  Targeted proteolysis of the focal adhesion kinase pp125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. , 1996, Oncogene.

[34]  J. Guan,et al.  Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. , 2001, Molecular biology of the cell.

[35]  G. Rosen,et al.  Cleavage of Focal Adhesion Kinase by Caspases during Apoptosis* , 1997, The Journal of Biological Chemistry.

[36]  D. V. Von Hoff,et al.  Identification of Thioredoxin-Interacting Protein 1 as a Hypoxia-Inducible Factor 1&agr;-Induced Gene in Pancreatic Cancer , 2008, Pancreas.

[37]  W. Cance,et al.  Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  V. Golubovskaya,et al.  Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. , 2006, Cancer research.

[39]  Paolo P. Provenzano,et al.  Tumorigenesis and Neoplastic Progression Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer , 2008 .

[40]  E. Rozengurt,et al.  Focal adhesion kinase (p125FAK): A point of convergence in the action of neuropeptides, integrins, and oncogenes , 1992, Cell.

[41]  D. Neal,et al.  MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion , 2003, Oncogene.

[42]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  V. Kosma,et al.  Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[45]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[46]  B. van de Water,et al.  Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. , 2005, Cancer research.

[47]  V. Golubovskaya,et al.  Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. , 2003, Molecular cancer research : MCR.

[48]  S. Scully,et al.  Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells. , 2004, The Biochemical journal.

[49]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[50]  Adam A. Margolin,et al.  PEG10 is a c-MYC target gene in cancer cells. , 2006, Cancer research.